Basel Medical (BMGL) Short term Debt (2024 - 2025)

Basel Medical (BMGL) posted Short term Debt of $887764.0 for Q4 2025, down 45.52% sequentially from $1.6 million in Q2 2025, and up 81.44% YoY from $489275.0 in Q4 2024.

Basel Medical (BMGL) Short term Debt (2024 - 2025) Analysis & Trends

Basel Medical has reported Short term Debt for 2 years, with the latest figure at $887764.0 in Q4 2025.

  • Quarterly Short term Debt rose 81.44% year-over-year to $887764.0 in Q4 2025, while the trailing twelve-month figure through Dec 2025 was $887764.0 (up 81.44% YoY) and the FY2025 annual result came in at $1.5 million, up 10.59% from the prior year.
  • Short term Debt declined to $887764.0 in Q4 2025 per BMGL's latest filing, from $1.6 million in the prior quarter.
  • Over five years, Short term Debt peaked at $2.0 million in Q2 2024 and troughed at $489275.0 in Q4 2024.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 HCA Healthcare 88.19 Bn 90.61 Bn 15.19 Bn
2 Tenet Healthcare 21.59 Bn 21.56 Bn 4.45 Bn
3 Encompass Health 12.19 Bn 12.86 Bn 1.34 Bn
4 Davita 11.52 Bn 12.39 Bn 1.16 Bn
5 Ensign 10.59 Bn 10.27 Bn 306.24 Mn
6 Universal Health Services 8.79 Bn 8.72 Bn 3.29 Bn
7 Pacs 7.04 Bn 6.88 Bn 338.46 Mn
8 Chemed 6.96 Bn 6.92 Bn 221.47 Mn
9 Concentra Group Holdings Parent 4.52 Bn 4.38 Bn 192.10 Mn
10 Basel Medical 98.81 Mn 98.02 Mn -

Historic Data

Download Data
DateValue
Dec 31, 2025 887,764.00
Jun 30, 2025 1.63 Mn
Dec 31, 2024 489,275.00
Jun 30, 2024 2.00 Mn